Brinckerhoff Quoted on USPTO

23 October 2009 BNA’s Life Sciences Law & Industry Report News
Foley Partner Courtenay Brinckerhoff was quoted in an article titled "PTO Decision to Rescind Continuation, RCE Rules Applauded" in the October 23, 2009 issue of BNA's Life Sciences Law & Industry Report. Brinckerhoff discusses the U.S. Patent and Trademark Office’s decision to rescind final rules limiting patent continuation and claims practice, noting that continuations and RCEs are often required in life sciences applications to obtain a scope of patent protection that adequately covers the invention. She adds that USPTO Director David Kappos’ comments that the Patent Office will work to implement improvements to make the USPTO more efficient signals positive changes that are needed to improve the U.S patent process and maintain the vibrancy and competitiveness of many U.S. industries.

Related Services

Insights

A Review of Recent Whistleblower Developments
19 July 2019
Legal News: Whistleblower Developments
Blockchain: A Tool With a Future in Healthcare
18 July 2019
Health Care Law Today
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Does The U.S. Need STRONGER Patents?
16 July 2019
PTAB Trial Insights
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ